BZI-ROCE

According to Benzinga Pro, during Q1, BWX Technologies (NYSE:BWXT) earned $60.99 million, a 41.75% increase from the preceding quarter. BWX Technologies's sales decreased to $568.36 million, a 8.95% change since Q4. In Q4, BWX Technologies brought in $624.20 million in sales but only earned $43.03...

Viant Technology (NASDAQ:DSP) brought in sales totaling $41.72 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 17.08%, resulting in a loss of $9.38 million. In Q4, Viant Technology brought in $54.51 million in sales but lost $8.01 million in earnings. Why...

Benzinga Pro data, Atara Biotherapeutics (NASDAQ:ATRA) reported Q1 sales of $1.23 million. Earnings fell to a loss of $74.77 million, resulting in a 0.27% decrease from last quarter. Atara Biotherapeutics collected $221 thousand in revenue during Q4, but reported earnings showed a $74.57 million...

Benzinga Pro data, Lincoln Educational Servs (NASDAQ:LINC) reported Q1 sales of $87.28 million. Earnings fell to a loss of $109 thousand, resulting in a 101.27% decrease from last quarter. In Q4, Lincoln Educational Servs earned $8.56 million, and total sales reached $91.78 million. What Is ROCE...

According to Benzinga Pro, during Q1, ANI Pharmaceuticals (NASDAQ:ANIP) earned $1.44 million, a 133.91% increase from the preceding quarter. ANI Pharmaceuticals also posted a total of $106.79 million in sales, a 13.32% increase since Q4. In Q4, ANI Pharmaceuticals brought in $94.23 million in sales...

Pulled from Benzinga Pro data, EchoStar (NASDAQ:SATS) posted Q1 earnings of $27.82 million, an increase from Q4 of 41.53%. Sales dropped to $439.60 million, a 12.06% decrease between quarters. In Q4, EchoStar earned $47.58 million, and total sales reached $499.86 million. What Is ROIC? Earnings...

According to Benzinga Pro, during Q1, Talos Energy (NYSE:TALO) earned $89.86 million, a 3167.64% increase from the preceding quarter. Talos Energy's sales decreased to $322.58 million, a 5.73% change since Q4. In Q4, Talos Energy earned $2.75 million, whereas sales reached $342.20 million. Why Is...

Benzinga Pro data, Pactiv Evergreen (NASDAQ:PTVE) reported Q1 sales of $1.43 billion. Earnings fell to a loss of $133.00 million, resulting in a 592.59% decrease from last quarter. In Q4, Pactiv Evergreen earned $27.00 million, and total sales reached $1.48 billion. What Is ROCE? Return on...

ARKO (NASDAQ:ARKO) brought in sales totaling $2.09 billion during Q1 according to data provided by Benzinga Pro. However, earnings decreased 119.65%, resulting in a loss of $2.53 million. ARKO earned $12.86 million, and sales totaled $2.18 billion in Q4. What Is ROCE? Earnings data without context...

ACADIA Pharmaceuticals (NASDAQ:ACAD) brought in sales totaling $118.46 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 3.11%, resulting in a loss of $43.02 million. ACADIA Pharmaceuticals collected $136.49 million in revenue during Q4, but reported earnings...

Benzinga Pro data, FibroGen (NASDAQ:FGEN) reported Q1 sales of $36.16 million. Earnings fell to a loss of $76.70 million, resulting in a 15.91% decrease from last quarter. In Q4, FibroGen brought in $34.37 million in sales but lost $66.17 million in earnings. What Is Return On Invested Capital?...

According to Benzinga Pro, during Q2, Hillenbrand (NYSE:HI) earned $463.50 million, a 869.67% increase from the preceding quarter. Hillenbrand also posted a total of $691.00 million in sales, a 5.38% increase since Q1. In Q1, Hillenbrand earned $47.80 million, and total sales reached $655.70...

According to Benzinga Pro data, during Q1, CRISPR Therapeutics (NASDAQ:CRSP) posted sales of $100.00 million. Earnings were up 52.01%, but CRISPR Therapeutics still reported an overall loss of $53.06 million. CRISPR Therapeutics collected $6 thousand in revenue during Q4, but reported earnings...

Benzinga Pro data, Tactile Systems Tech (NASDAQ:TCMD) reported Q1 sales of $58.85 million. Earnings fell to a loss of $1.89 million, resulting in a 140.81% decrease from last quarter. Tactile Systems Tech earned $4.62 million, and sales totaled $73.90 million in Q4. What Is Return On Capital...

Treace Medical Concepts (NASDAQ:TMCI) brought in sales totaling $42.20 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 204.94%, resulting in a loss of $13.45 million. In Q4, Treace Medical Concepts brought in $49.77 million in sales but lost $4.41 million...